HERCULES, CA--(Marketwired - Jul 29, 2013) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic ...
HERCULES, CA--(Marketwired - Feb 25, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) today announced CE IVD marking for its QX200™ Droplet Digital™ PCR (ddPCR™) System, the first ...
In the first study 1, clinicians in Wuhan, China observed that a subset of infected individuals who tested negative for COVID-19 using qPCR tested positive using ddPCR. The findings suggest that ddPCR ...
Bio-Rad Laboratories and has announced CE IVD marking for its QX200™ Droplet Digital™ PCR (ddPCR™) System, the first digital PCR system with the CE IVD mark for use as an in vitro diagnostic (IVD) in ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR™) ...
In July 2013, Bio-Rad launched its second-generation ddPCR instrument, the QX200' Droplet Digital' PCR System. This instrument enables the use of both EvaGreen and TaqMan hydrolysis probe detection ...
HERCULES, CA--(Marketwired - February 25, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) today announced CE IVD marking for its QX200™ Droplet Digital™ PCR (ddPCR™) System, the first ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that in two studies ...
The QX200 system is the only digital PCR system that works with EvaGreen and TaqMan hydrolysis probes (reagents that are used with the instrument) to provide users more flexibility in the design of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results